William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
International Classification:
A61K048/00 C12N005/08
US Classification:
435/366000, 424/093210
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K048/00 C12N005/08
US Classification:
424/093210, 435/368000, 435/372000
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K049/00 C12N005/08
US Classification:
424/009100, 435/366000
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
C12M001/26 C12N005/02
US Classification:
424/093700, 435/325000, 435/309100
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K048/00
US Classification:
424/093210, 424/093700
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K045/00 C12N005/08
US Classification:
424/093700, 435/372000, 435/368000
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K048/00 C12N005/08
US Classification:
424/093210, 424/093700, 435/372000
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Embryonic Stem Cells, Clinical Applications And Methods For Expanding In Vitro
William Rader - Malibu CA, US Albert Scheller - Tegernsee, DE
Assignee:
Medra, Inc.
International Classification:
A61K048/00 C12N005/08
US Classification:
424/093210, 424/093700, 435/368000, 435/372000
Abstract:
The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders.
Dr. Rader has been the only American physician researching the therapeutic applications of fetal stem cell therapy. In 1995 he founded Stem Cell of America, an international corporation dedicated to t...
Tagline:
Pioneer of Stem Cell Science
Bragging Rights:
Chief scientist and medical director at Stem Cell of America
David Garrett, Brenda Thompson, Donna Mcdaniel, Mark Bales, Malinda Alexander, Dana Davis, Tammy Headgepath, Steve Ball, Patricia Henderson, Marsha Kraus, Susan Reed